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respective Wistar (W) control rat, or hereditary hypertriglyceridemic
(HHTg) rats with or without high sucrose diet (HSD) aged 14, 9 and
3 monthswere investigated. Lentiviral particles containingMito-GFP or
SSBP1-Eos were used to transfect beta cells separated by acutase
from the isolated Langerhans islets [1]. β-cells isolated from W and
HHTg (3 and 9 months) without HSD were easily susceptible for trans-
duction byMito-GFP, while GK showedminimal transduction rate with
fragmentedmitochondria.β-cells fromHHTg+ HSD (14 months)were
not transducible by Mito-GFP at all. Only β-cells from W and HHTg
(3 and 9 months) were susceptible for transduction by SSBP1-Eos. Our
pilot study shows certain difﬁculties with lentiviral transduction of
Mito-GFP and SSBP1-Eos in elder animals with diabetic or pre-diabetic
pathology. Based on these results, certain level of relationship between
metabolic state in β-cells with turnover of mitochondrial and nucleoid
components is discussed. Supported by GACR grant no. 13-06666.
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Background: Lon is a nuclear-encoded, mitochondrial ATP-
dependent protease that assists protein folding, degrades oxidized/
damaged proteins and participates in maintaining mitochondrial
DNA (mtDNA) levels. Here we show that Lon is upregulated in
several human cancers, including the colon cancer derived cell line
RKO, and that its silencing in these cells causes profound alterations
of mitochondrial proteome and massive cell death. Materials and
methods: Lon mRNA was downregulated by RNA interference using
two vectors for constitutive and inducible (doxycycline-regulated)
expression of Lon short hairpin RNA. Mitochondrial proteome was
analysed by 2-dimensional gel electrophoresis and mass spectrom-
etry. Mitochondrial DNA and RNA were quantiﬁed by real time
PCR. Apoptosis, content of mitochondrial anion superoxide and
cellular hydrogen peroxide, and mitochondrial membrane potential
were measured by ﬂow cytometry. Mitochondrial morphology was
analysed by confocal and transmission electron microscopy. Results
and discussion: Lon silencing in RKO colon cancer cells caused
profound alterations of mitochondrial proteome, and massive cell
death. Mitochondria of Lon-silenced cells displayed levels of mtDNA
comparable to those of control cells, but low levels of
mtDNA transcripts, reduced levels of several subunits of oxidative
phosphorylation complexes (complex I being the most affected), a
marked reduction of oxygen consumption rate, and impaired
capability to synthetize ATP. Higher levels of hydrogen peroxide
and mitochondrial superoxide anion were also observed. Mitochon-
drial network appeared fragmented, with mitochondria heteroge-
neous in size and shape, dilated cristae, vacuoles and electron-dense
inclusions. The triterpenoid 2-cyano-3,12-dioxooleana-1,9,-dien-28-
oic acid, an inhibitor of Lon proteolytic activity, was able to partially
mimic Lon silencing. Conclusion: Lon is essential for maintaining
mitochondrial shape and functions, and for the survival of RKO colon
cancer cells.
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HepG2 cells cultivated in glucose media adapted to hypoxia (5%
oxygen, 72 h) show metabolic shift to glycolysis at the expense of
mitochondrial bioenergetics, called Warburg effect. This is accompa-
nied by a drop of mitochondrial superoxide release into the matrix.
We found that mitochondrial morphology of those cells is changed,
i.e., the mitochondrial intermembrane space and mostly intracristal
space are expanded, using 3D superresolution (~30 nm) Biplane
FPALM microscopy [1] in combination with Eos-conjugated markers
of desired mitochondrial compartments. In parallel, cryo-preserved
electron microscopy has been performed, indicating cristae width
increase from 18 ± 5 to 24 ± 10 nm at 5 mM glucose. The observed
cristae expansion was accompanied by 20–30% downregulation of
cristae-shaping protein mitoﬁlin and enhanced OPA1 processing into
shorter isoforms. To explain such hypoxia-adapted cristae inﬂation,
we propose that the intracristal space volume increase releases
proton motive force control of proton pumping into expanded
cristae compartments and thus diminishes superoxide formation.
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